BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18326893)

  • 21. Management of low-stage testicular seminoma.
    Neill M; Warde P; Fleshner N
    Urol Clin North Am; 2007 May; 34(2):127-36; abstract vii-viii. PubMed ID: 17484918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial risks in testicular cancer as aetiological clues.
    Hemminki K; Chen B
    Int J Androl; 2006 Feb; 29(1):205-10. PubMed ID: 16466541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for testicular cancer--differences between pure non-seminoma and mixed seminoma/non-seminoma?
    Aschim EL; Haugen TB; Tretli S; Daltveit AK; Grotmol T
    Int J Androl; 2006 Aug; 29(4):458-67. PubMed ID: 16487404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synchronous and metachronous bilateral testicular germ cell tumors].
    Li YX
    Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):448-50. PubMed ID: 8200285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
    Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular germ cell tumors in patients with human immunodeficiency virus infection.
    Hentrich MU; Brack NG; Schmid P; Schuster T; Clemm C; Hartenstein RC
    Cancer; 1996 May; 77(10):2109-16. PubMed ID: 8640678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular, other genital, and breast cancers in first-degree relatives of testicular cancer patients and controls.
    Bromen K; Stang A; Baumgardt-Elms C; Stegmaier C; Ahrens W; Metz KA; Jöckel KH
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1316-24. PubMed ID: 15298952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
    Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
    Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
    Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
    Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant testicular neoplasms in immunosuppressed patients.
    Leibovitch I; Baniel J; Rowland RG; Smith ER; Ludlow JK; Donohue JP
    J Urol; 1996 Jun; 155(6):1938-42. PubMed ID: 8618292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.
    Clarke K; Howard GC; Elia MH; Hutcheon AW; Kaye SB; Windsor PM; Yosef HM
    Br J Cancer; 1995 Nov; 72(5):1300-2. PubMed ID: 7577486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increased incidence of sarcoma in patients treated for seminoma].
    Jacobsen GK; Mellemgaard A; Engelholm SA; Møller H
    Ugeskr Laeger; 1994 Feb; 156(6):809-12. PubMed ID: 8016985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 18 years study of testicular tumours in Jodhpur, western Rajasthan.
    Deotra A; Mathur DR; Vyas MC
    J Postgrad Med; 1994; 40(2):68-70. PubMed ID: 8737555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histology-specific risks in testicular cancer in immigrants to Sweden.
    Hemminki K; Mousavi SM; Brandt A; Ji J; Sundquist J
    Endocr Relat Cancer; 2010 Jun; 17(2):329-34. PubMed ID: 20228136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic.
    Dusek L; Abrahamova J; Lakomy R; Vyzula R; Koptikova J; Pavlik T; Muzik J; Klimes D
    Neoplasma; 2008; 55(4):356-68. PubMed ID: 18505349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome.
    Yoshida T; Kakimoto K; Takezawa K; Arai Y; Ono Y; Meguro N; Kinouchi T; Nishimura K; Usami M
    Int J Urol; 2009 Sep; 16(9):756-9. PubMed ID: 19659679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual and seminal characteristics of patients with testicular germ cell tumors.
    Fraietta R; Spaine DM; Bertolla RP; Ortiz V; Cedenho AP
    Fertil Steril; 2010 Nov; 94(6):2107-12. PubMed ID: 20117767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular cancer incidence in eight northern European countries: secular and recent trends.
    Richiardi L; Bellocco R; Adami HO; Torrång A; Barlow L; Hakulinen T; Rahu M; Stengrevics A; Storm H; Tretli S; Kurtinaitis J; Tyczynski JE; Akre O
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2157-66. PubMed ID: 15598775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post orchiectomy management in stage II testicular seminoma.
    Singhal S; Dixit S; Murthy RR; Neema JP; Vyas RK; Baboo HA
    Indian J Cancer; 1994 Dec; 31(4):226-34. PubMed ID: 7533129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma].
    Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Grosclaude P
    Prog Urol; 1999 Sep; 9(4):689-95. PubMed ID: 10555222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.